CRIXIVAN
Brand-level analytics aggregated across all owners and jurisdictions using this name.
Total filings
7
Live
3
Live %
42.9%
Distinct owners
3
Jurisdictions
7
Top NICE
5Pharmaceuticals
Owners Using This Brand Name
| # | Owner | Country | Filings |
|---|---|---|---|
| 1 | Merck Sharp & Dohme LLC | US | 3 |
| 2 | MERCK & CO., INC. | US | 1 |
| 3 | MERCK & CO., INC | US | 1 |
| 4 | Merck Sharp & Dohme Corp. | US | 1 |
| 5 | SCHERING CORPORATION | US | 1 |
Geographic Coverage
Filing presence across major commercial IP offices. Color intensity is a log scale of filing count -- darker = more filings. Gaps may indicate expansion opportunities or unprotected markets.
Madrid Protocol (WIPO)
Less
More·Log scale
4 covered · 34 gaps · 38 target jurisdictions
Targets are major commercial IP offices. Gaps may indicate expansion opportunities or unprotected risk.
US○
United States
—
JP○
Japan
—
GB○
United Kingdom
—
IT●
Italy
1
TW○
Taiwan
—
EM○
European Union (EUIPO)
—
CN○
China
—
KR○
South Korea
—
HK○
Hong Kong
—
IN○
India
—
CA○
Canada
—
AU○
Australia
—
NZ○
New Zealand
—
DE○
Germany
—
FR○
France
—
ES○
Spain
—
CH○
Switzerland
—
NL○
Netherlands
—
BX○
Benelux
—
SE○
Sweden
—
NO●
Norway
1
PL○
Poland
—
TR○
Turkey
—
RU○
Russia
—
BR○
Brazil
—
MX○
Mexico
—
AR○
Argentina
—
AE○
United Arab Emirates
—
SA○
Saudi Arabia
—
IL●
Israel
1· 0 live
ZA○
South Africa
—
SG○
Singapore
—
MY○
Malaysia
—
TH○
Thailand
—
ID○
Indonesia
—
PH●
Philippines
1· 0 live
VN○
Vietnam
—
WO○
Madrid (WIPO)
—
By Jurisdiction
| Jurisdiction | Total | Live |
|---|---|---|
| PH | 1 | 0 |
| LA | 1 | 0 |
| IL | 1 | 0 |
| HR | 1 | 0 |
| IT | 1 | 1 |
| NO | 1 | 1 |
| TT | 1 | 1 |
Recent Filings
| Date | Owner | Status | NICE | App # |
|---|---|---|---|---|
| 2000-06-16 | Abandoned | 5 | PH4200000004991 | |
| 2000-05-23 | Registered | 5 | 302000900848317 | |
| 1992-09-29 | Cancelled | 5 | Ž920967A | |
| 1992-03-12 | Cancelled | 5 | 681 | |
| 1991-12-06 | Registered | 1 | N/M/1/020317 | |
| 1991-11-22 | Cancelled | 5 | 81650 | |
| 1991-11-20 | Registered | 5 | 19915867 |